Search research articles
Contact Us
Filters
Showing results (1-10 of 128) with videos related to
Page
of 13
Sort By:
Presse Medicale (Paris, France : 1983)
|
February 8, 2022
Molecular Imaging in neuroendocrine neoplasias
Emanuel Christ, Damian Wild, Julie Refardt
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Somatostatin Receptor Antagonists for Imaging and Therapy
Melpomeni Fani, Guillaume P Nicolas, Damian Wild
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 18, 2017
Reply: Advantages and Limits of Targeted Radionuclide Therapy with Somatostatin Antagonists
Guillaume P Nicolas, Damian Wild, Melpomeni Fani
The New England Journal of Medicine
|
September 24, 2010
GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle
Francois Pattou, Julie Kerr-Conte, Damian Wild
Endocrinology and Metabolism Clinics of North America
|
November 25, 2010
Glucagonlike peptide-1 receptor: an example of translational research in insulinomas: a review
Emanuel Christ, Damian Wild, Jean Claude Reubi
Endocrine-Related Cancer
|
January 18, 2020
Innovative imaging of insulinoma: the end of sampling? A review
Emanuel Christ, Kwadwo Antwi, Melpomeni Fani, et al.
Current Oncology Reports
|
November 4, 2021
New Directions in Imaging Neuroendocrine Neoplasms
Julie Refardt, Johannes Hofland, Damian Wild, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 5, 2022
Molecular Imaging of Neuroendocrine Neoplasms
Julie Refardt, Johannes Hofland, Damian Wild, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
March 15, 2016
Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging
Tobias Baumann, Christof Rottenburger, Guillaume Nicolas, et al.
Swiss Medical Weekly
|
April 4, 2019
Erratum to: Molecular imaging for neuroendeocrine tumours
Antwi Kwadwo, Nicolas Guillaume, Damian Wild, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 128) with videos related to
Sort By:
Page
of 13
Presse Medicale (Paris, France : 1983)
|
February 8, 2022
Molecular Imaging in neuroendocrine neoplasias
Emanuel Christ, Damian Wild, Julie Refardt
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Somatostatin Receptor Antagonists for Imaging and Therapy
Melpomeni Fani, Guillaume P Nicolas, Damian Wild
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 18, 2017
Reply: Advantages and Limits of Targeted Radionuclide Therapy with Somatostatin Antagonists
Guillaume P Nicolas, Damian Wild, Melpomeni Fani
The New England Journal of Medicine
|
September 24, 2010
GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle
Francois Pattou, Julie Kerr-Conte, Damian Wild
Endocrinology and Metabolism Clinics of North America
|
November 25, 2010
Glucagonlike peptide-1 receptor: an example of translational research in insulinomas: a review
Emanuel Christ, Damian Wild, Jean Claude Reubi
Endocrine-Related Cancer
|
January 18, 2020
Innovative imaging of insulinoma: the end of sampling? A review
Emanuel Christ, Kwadwo Antwi, Melpomeni Fani, et al.
Current Oncology Reports
|
November 4, 2021
New Directions in Imaging Neuroendocrine Neoplasms
Julie Refardt, Johannes Hofland, Damian Wild, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 5, 2022
Molecular Imaging of Neuroendocrine Neoplasms
Julie Refardt, Johannes Hofland, Damian Wild, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
March 15, 2016
Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging
Tobias Baumann, Christof Rottenburger, Guillaume Nicolas, et al.
Swiss Medical Weekly
|
April 4, 2019
Erratum to: Molecular imaging for neuroendeocrine tumours
Antwi Kwadwo, Nicolas Guillaume, Damian Wild, et al.
Page
of 13